Riverwater Partners LLC Invests $1.59 Million in Integer Holdings Co. (NYSE:ITGR)

Riverwater Partners LLC acquired a new position in shares of Integer Holdings Co. (NYSE:ITGR) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,982 shares of the medical equipment provider’s stock, valued at approximately $1,588,000.

Other large investors also recently modified their holdings of the company. Raymond James Financial Inc. acquired a new position in Integer in the fourth quarter valued at approximately $38,073,000. Artisan Partners Limited Partnership acquired a new position in shares of Integer during the 4th quarter valued at $22,775,000. Laurus Investment Counsel Inc. bought a new position in Integer during the fourth quarter worth $5,422,000. New York State Common Retirement Fund grew its holdings in Integer by 20.9% in the fourth quarter. New York State Common Retirement Fund now owns 232,569 shares of the medical equipment provider’s stock worth $30,820,000 after purchasing an additional 40,158 shares during the period. Finally, Wealthfront Advisers LLC bought a new stake in Integer in the fourth quarter valued at $4,754,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ITGR has been the subject of several research reports. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Benchmark boosted their price objective on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, February 21st. KeyCorp increased their target price on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Citigroup boosted their price target on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Finally, Truist Financial raised their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $148.56.

Integer Stock Down 1.9 %

ITGR opened at $113.87 on Friday. Integer Holdings Co. has a fifty-two week low of $107.11 and a fifty-two week high of $146.36. The firm has a market capitalization of $3.83 billion, a P/E ratio of 33.89, a PEG ratio of 1.72 and a beta of 1.24. The company’s 50-day moving average is $128.00 and its 200 day moving average is $131.69. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to analysts’ expectations of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. Research analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.